Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight ReductionChikara Komiya, Yoshihiro Ogawa|PLoS ONE|2016Cited by 229
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitisChikara Komiya, Yoshihiro Ogawa|Scientific Reports|2017Cited by 64